Allgens Medical Technology CO., LTD.
Символ: 688613.SS
SHH
15.57
CNYПазарна цена днес
45.4188
Съотношение P/E
0.0000
Коефициент PEG
2.08B
MRK Cap
- 0.01%
Доходност на DIV
Allgens Medical Technology CO., LTD. (688613-SS) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1063.4 | 1076 | 1065.2 | |||||||
balance-sheet.row.short-term-investments | 0 | 902.2 | 816.1 | 653.9 | |||||||
balance-sheet.row.net-receivables | 0 | 73.4 | 44.2 | 32.6 | |||||||
balance-sheet.row.inventory | 0 | 32.7 | 18.3 | 19 | |||||||
balance-sheet.row.other-current-assets | 0 | 31.3 | 3.9 | 4.1 | |||||||
balance-sheet.row.total-current-assets | 0 | 1200.7 | 1142.3 | 1120.9 | |||||||
balance-sheet.row.property-plant-equipment-net | 0 | 186.6 | 188.8 | 195.5 | |||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.intangible-assets | 0 | 22.1 | 23.4 | 24.6 | |||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 22.1 | 23.4 | 24.6 | |||||||
balance-sheet.row.long-term-investments | 0 | 1254.8 | 58.6 | 65.8 | |||||||
balance-sheet.row.tax-assets | 0 | 21.7 | 18.6 | 14.2 | |||||||
balance-sheet.row.other-non-current-assets | 0 | -1159.7 | 27.5 | 5 | |||||||
balance-sheet.row.total-non-current-assets | 0 | 325.5 | 316.9 | 305.2 | |||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-assets | 0 | 1526.3 | 1459.2 | 1426.1 | |||||||
balance-sheet.row.account-payables | 0 | 10.4 | 7.4 | 3.3 | |||||||
balance-sheet.row.short-term-debt | 0 | 5.1 | 15.7 | 19.1 | |||||||
balance-sheet.row.tax-payables | 0 | 1.9 | 6.5 | 2.8 | |||||||
balance-sheet.row.long-term-debt-total | 0 | 48.3 | 45.9 | 61.5 | |||||||
Deferred Revenue Non Current | 0 | 22.2 | 34.9 | 36.2 | |||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||
balance-sheet.row.other-current-liab | 0 | 0.3 | 21.4 | 0.1 | |||||||
balance-sheet.row.total-non-current-liabilities | 0 | 71.8 | 85 | 100.3 | |||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.capital-lease-obligations | 0 | 3 | 5 | 5 | |||||||
balance-sheet.row.total-liab | 0 | 122.6 | 133.5 | 155.5 | |||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.common-stock | 0 | 133.3 | 133.3 | 133.3 | |||||||
balance-sheet.row.retained-earnings | 0 | 276 | 239.2 | 190.8 | |||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1366.1 | 55 | 44.8 | |||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -393.3 | 875.3 | 875.3 | |||||||
balance-sheet.row.total-stockholders-equity | 0 | 1382.1 | 1302.9 | 1244.3 | |||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1526.3 | 1459.2 | 1426.1 | |||||||
balance-sheet.row.minority-interest | 0 | 21.6 | 22.8 | 26.3 | |||||||
balance-sheet.row.total-equity | 0 | 1403.6 | 1325.7 | 1270.6 | |||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||
Total Investments | 0 | 2157 | 816.1 | 653.9 | |||||||
balance-sheet.row.total-debt | 0 | 53.4 | 61.6 | 80.6 | |||||||
balance-sheet.row.net-debt | 0 | -107.8 | -198.3 | -330.7 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 91.7 | 118.1 | 87.1 | ||||||
cash-flows.row.depreciation-and-amortization | 0 | 18 | 13.2 | 10.9 | ||||||
cash-flows.row.deferred-income-tax | 0 | -2.8 | -1.7 | -6.1 | ||||||
cash-flows.row.stock-based-compensation | 0 | 2.8 | 1.7 | 6.1 | ||||||
cash-flows.row.change-in-working-capital | 0 | -2.5 | 6.9 | -11.8 | ||||||
cash-flows.row.account-receivables | 0 | -12.2 | -9.5 | -9.2 | ||||||
cash-flows.row.inventory | 0 | 0.7 | 1.8 | -14.6 | ||||||
cash-flows.row.account-payables | 0 | 11.8 | 16.2 | 18.1 | ||||||
cash-flows.row.other-working-capital | 0 | -2.8 | -1.7 | -6.1 | ||||||
cash-flows.row.other-non-cash-items | 0 | -5.2 | -8.3 | -1.3 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -45.4 | -61.2 | -56.4 | ||||||
cash-flows.row.acquisitions-net | 0 | 0 | 168.3 | 478.2 | ||||||
cash-flows.row.purchases-of-investments | 0 | -168 | -204 | -478.2 | ||||||
cash-flows.row.sales-maturities-of-investments | 0 | 16 | 35.7 | 14.2 | ||||||
cash-flows.row.other-investing-activites | 0 | 0 | -168.3 | -101.1 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -197.4 | -229.5 | -143.3 | ||||||
cash-flows.row.debt-repayment | 0 | -8.6 | -34.6 | -2.6 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | -7.7 | 0 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 7.7 | 0 | ||||||
cash-flows.row.dividends-paid | 0 | -40.1 | -1.2 | -1.4 | ||||||
cash-flows.row.other-financing-activites | 0 | -7.1 | 526 | 8.2 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -55.8 | 490.2 | 4.2 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -0.3 | 0 | -0.1 | ||||||
cash-flows.row.net-change-in-cash | 0 | -151.4 | 390.5 | -54.3 | ||||||
cash-flows.row.cash-at-end-of-period | 0 | 259.9 | 411.3 | 20.8 | ||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 411.3 | 20.8 | 75.1 | ||||||
cash-flows.row.operating-cash-flow | 0 | 102.1 | 129.8 | 84.9 | ||||||
cash-flows.row.capital-expenditure | 0 | -45.4 | -61.2 | -56.4 | ||||||
cash-flows.row.free-cash-flow | 0 | 56.6 | 68.5 | 28.5 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 226.5 | 245.3 | 236.1 | |||||||
income-statement-row.row.cost-of-revenue | 0 | 39.2 | 40.8 | 34.6 | |||||||
income-statement-row.row.gross-profit | 0 | 187.2 | 204.5 | 201.5 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.other-expenses | 0 | -177.4 | 23.8 | 20.3 | |||||||
income-statement-row.row.operating-expenses | 0 | 177.4 | 121.3 | 80.7 | |||||||
income-statement-row.row.cost-and-expenses | 0 | 177.4 | 162 | 115.3 | |||||||
income-statement-row.row.interest-income | 0 | 3.3 | 5.6 | 4.3 | |||||||
income-statement-row.row.interest-expense | 0 | 3.1 | 1.9 | 3.4 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 0 | 0.1 | -0.1 | -2.9 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | 0 | -177.4 | 23.8 | 20.3 | |||||||
income-statement-row.row.total-operating-expenses | 0 | 0.1 | -0.1 | -2.9 | |||||||
income-statement-row.row.interest-expense | 0 | 3.1 | 1.9 | 3.4 | |||||||
income-statement-row.row.depreciation-and-amortization | 0 | 18 | 10.5 | 0.9 | |||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||
income-statement-row.row.operating-income | 0 | 49 | 96.3 | 134.9 | |||||||
income-statement-row.row.income-before-tax | 0 | 49.1 | 96.2 | 132 | |||||||
income-statement-row.row.income-tax-expense | 0 | -3.9 | 4.5 | 14 | |||||||
income-statement-row.row.net-income | 0 | 54.2 | 95.2 | 120.8 |
Често задавани въпроси
Какво е Allgens Medical Technology CO., LTD. (688613.SS) общи активи?
Allgens Medical Technology CO., LTD. (688613.SS) общите активи са 1526256853.000.
Какъв е годишният приход на предприятието?
Годишните приходи са N/A.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.195.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.195.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.198.
Какъв е общият приход на предприятието?
Общият приход е 0.141.
Каква е Allgens Medical Technology CO., LTD. (688613.SS) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 54231840.000.
Какъв е общият дълг на фирмата?
Общият дълг е 53416683.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 177437900.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 0.000.